Glenn Frank, Chief Scientific Officer at Atai Life Sciences N.V. ($ATAI), sold shares on the open market once in the last year for a total of $17,767, with the most recent sale on March 21, 2025. His sales rank 11,089th among 11,678 individual insiders, well below the average of $8.6 million per seller and 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 21, 2025 | Atai Beckley N.V. | $ATAI | Short Glenn Frank | Chief Scientific Officer | S | Common Shares | 13161 | $1.35 | 42,333.0000 | 198,306,455 | 23.72% | 0.01% |
| March 14, 2025 | Atai Beckley N.V. | $ATAI | Short Glenn Frank | Chief Scientific Officer | M | Common Shares | 32500 | $0.00 | 55,494.0000 | 198,306,455 | 141.34% | 0.02% |
| March 14, 2025 | Atai Beckley N.V. | $ATAI | Short Glenn Frank | Chief Scientific Officer | M | Restricted Stock Units | 32500 | $0.00 | 0.0000 | 198,306,455 | 100.00% | 0.02% |
| March 3, 2025 | Atai Beckley N.V. | $ATAI | Short Glenn Frank | Chief Scientific Officer | A | Stock Option | 757915 | $0.00 | 757,915.0000 | 0 | 9999.99% | 0.00% |